Boehringer Ingelheim ToMORROW® (cephapirin benzathine)

ToMORROW gives dairy producers time-tested, broad-spectrum control against the harmful organisms that cause mastitis in dry cows. ToMORROW has been an effective extended therapy treatment for more than 25 years, and studies have shown no change in the development of bacterial resistance.1,2 ToMORROW has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows, when caused by Streptococcus agalactiae and Staphylococcus aureus including penicillin-resistant strains. ToMORROW is formulated with cephapirin benzathine to provide broad spectrum and long-acting therapy that dry cows need. Presentations: Pail containing 144 x 10 mL syringes and 144 convenient single use alcohol pads. Cartons containing 12 x 10 mL syringes with 12 convenient single use alcohol pads. Partial insertion reduces new infections. With the Opti-Sert® applicator tip, partial insertion reduces the incidence of new infections during the dry period. Studies have shown th